BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33745961)

  • 21. Reference Ranges, Diagnostic and Prognostic Utility of Native T1 Mapping and Extracellular Volume for Cardiac Amyloidosis: A Meta-Analysis.
    Wang TKM; Brizneda MV; Kwon DH; Popovic ZB; Flamm SD; Hanna M; Griffin BP; Xu B
    J Magn Reson Imaging; 2021 May; 53(5):1458-1468. PubMed ID: 33274809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial ECV Fraction Assessed by CMR Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot.
    Chen CA; Dusenbery SM; Valente AM; Powell AJ; Geva T
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):1-10. PubMed ID: 26684969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of diffuse myocardial fibrosis using CMR extracellular volume fraction and serum biomarkers of collagen turnover with histologic quantification as standard of reference.
    Foussier C; Barral PA; Jerosh-Herold M; Gariboldi V; Rapacchi S; Gallon A; Bartoli A; Bentatou Z; Guye M; Bernard M; Jacquier A
    Diagn Interv Imaging; 2021 Mar; 102(3):163-169. PubMed ID: 32830084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phantom-based correction for standardization of myocardial native T1 and extracellular volume fraction in healthy subjects at 3-Tesla cardiac magnetic resonance imaging.
    Suh YJ; Kim PK; Park J; Park EA; Jung JI; Choi BW
    Eur Radiol; 2022 Dec; 32(12):8122-8130. PubMed ID: 35771246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension.
    Roller FC; Wiedenroth C; Breithecker A; Liebetrau C; Mayer E; Schneider C; Rolf A; Hamm C; Krombach GA
    Eur Radiol; 2017 May; 27(5):1980-1991. PubMed ID: 27651142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
    Vos JL; Lemmers JMJ; El Messaoudi S; Snoeren M; van Dijk APJ; Duijnhouwer AL; Rodwell L; van Leuven SI; Post MC; Vonk MC; Nijveldt R
    Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):708-717. PubMed ID: 38170546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pooled summary of native T1 value and extracellular volume with MOLLI variant sequences in normal subjects and patients with cardiovascular disease.
    Vo HQ; Marwick TH; Negishi K
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):325-336. PubMed ID: 31686277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis.
    Minegishi S; Kato S; Takase-Minegishi K; Horita N; Azushima K; Wakui H; Ishigami T; Kosuge M; Kimura K; Tamura K
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100422. PubMed ID: 31517037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial extracellular volume quantification by cardiac CT in pulmonary hypertension: Comparison with cardiac MRI.
    Hayashi H; Oda S; Emoto T; Kidoh M; Nagayama Y; Nakaura T; Sakabe D; Tokuyasu S; Hirakawa K; Takashio S; Yamamoto E; Tsujita K; Hirai T
    Eur J Radiol; 2022 Aug; 153():110386. PubMed ID: 35661458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.
    Miller CA; Naish JH; Bishop P; Coutts G; Clark D; Zhao S; Ray SG; Yonan N; Williams SG; Flett AS; Moon JC; Greiser A; Parker GJ; Schmitt M
    Circ Cardiovasc Imaging; 2013 May; 6(3):373-83. PubMed ID: 23553570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Accuracy of Cardiovascular Magnetic Resonance for Cardiac Transplant Rejection: A Meta-Analysis.
    Han D; Miller RJH; Otaki Y; Gransar H; Kransdorf E; Hamilton M; Kittelson M; Patel J; Kobashigawa JA; Thomson L; Berman D; Tamarappoo B
    JACC Cardiovasc Imaging; 2021 Dec; 14(12):2337-2349. PubMed ID: 34274269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients.
    Chaikriangkrai K; Abbasi MA; Sarnari R; Dolan R; Lee D; Anderson AS; Ghafourian K; Khan SS; Vorovich EE; Rich JD; Wilcox JE; Blaisdell JA; Yancy CW; Carr J; Markl M
    JACC Cardiovasc Imaging; 2020 Jul; 13(7):1521-1530. PubMed ID: 32199848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac magnetic resonance T1 mapping. Part 2: Diagnostic potential and applications.
    Reiter U; Reiter C; Kräuter C; Fuchsjäger M; Reiter G
    Eur J Radiol; 2018 Dec; 109():235-247. PubMed ID: 30539759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema.
    Yuan Y; Cai J; Cui Y; Wang J; Alwalid O; Shen X; Cao Y; Zou Y; Liang B
    Int J Cardiovasc Imaging; 2018 Dec; 34(12):1959-1967. PubMed ID: 30056496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
    Al-Wakeel-Marquard N; Seidel F; Herbst C; Kühnisch J; Kuehne T; Berger F; Klaassen S; Messroghli DR
    Int J Cardiol; 2021 Jun; 333():219-225. PubMed ID: 33737165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of myocardial magnetic resonance extracellular volume mapping at 3 T against histology of tissue collagen in severe aortic valve stenosis and obstructive hypertrophic cardiomyopathy.
    Bakermans AJ; Kouwenhoven M; de Vos J; de Vries DK; Reckman YJ; Farag ES; Koolbergen DR; Kluin J; Nederveen AJ; Strijkers GJ; Boekholdt SM
    MAGMA; 2023 Oct; 36(5):701-709. PubMed ID: 36820958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of native T1 mapping and myocardial extracellular volume fraction in patients with nonischemic dilated cardiomyopathy: A systematic review and meta-analysis.
    Tao M; Dhaliwal S; Ghosalkar D; Sheng S; Dianati-Maleki N; Tam E; Rahman T; Mann N; Kort S
    Int J Cardiol Heart Vasc; 2024 Apr; 51():101339. PubMed ID: 38371310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac involvement in non-cirrhotic portal hypertension: MRI detects myocardial fibrosis and oedema similar to compensated cirrhosis.
    Isaak A; Chang J; Mesropyan N; Kravchenko D; Endler C; Bischoff L; Böhling N; Pieper CC; Kuetting D; Strassburg CP; Attenberger U; Jansen C; Praktiknjo M; Luetkens JA
    Eur Heart J Cardiovasc Imaging; 2023 Jun; 24(7):949-960. PubMed ID: 36423215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.